Page last updated: 2024-08-24

sparfloxacin and Acute Disease

sparfloxacin has been researched along with Acute Disease in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (78.57)18.2507
2000's3 (21.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Y; Liang, D; Miao, J; Qiu, D; Wen, C; Xu, N1
Barlow, D; Gianotti, B; Jean, C; Moi, H; Morel, P; Phillips, I2
Allegra, L; Guyen, JN; Hosie, J; Konietzko, N; Leophonte, P; Pauwels, R; Petitpretz, P1
Berche, P; Gehanno, P1
Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D1
Dorr, MB; Ellison, W; Henry, D; Magner, DJ; Mansfield, DL; Sullivan, J; Talbot, GH1
Adelglass, J; Henry, DC; Jablonski, CK; Moller, DJ; Scheld, WM; Talbot, GH; Zhang, H1
Finch, RG1
Lipsky, BA; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H1
Buffington, D; Garrison, N; Granito, K; Spector, S; Stafford, C; Talbot, GH; Zhang, H1
Derevianko, II1
Kumamoto, Y1
Hirose, T; Miyake, M; Miyamoto, S; Miyao, N; Sato, T; Takatsuka, K; Tanaka, N; Umehara, T; Yokoo, A; Yoshiaki, K1

Reviews

1 review(s) available for sparfloxacin and Acute Disease

ArticleYear
A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis.
    International journal of antimicrobial agents, 1999, Volume: 12, Issue:1

    Topics: Acute Disease; Animals; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial

1999

Trials

13 trial(s) available for sparfloxacin and Acute Disease

ArticleYear
[Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2002, Volume: 33, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin

2002
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Quinolones; Urethritis

1995
Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A

    Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Middle Aged; Moraxella catarrhalis; Quinolones; Streptococcus pneumoniae

1996
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A

    Topics: Acute Disease; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Prodrugs; Quinolones; Sinusitis

1996
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Fluoroquinolones; Gonorrhea; Humans; International Cooperation; Male; Middle Aged; Quinolones; Urethritis

1996
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    Chest, 1998, Volume: 114, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome

1998
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urinary Tract Infections

1998
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.
    Clinical therapeutics, 1999, Volume: 21, Issue:2

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis

1999
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Clinical therapeutics, 1999, Volume: 21, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged

1999
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:1

    Topics: Acute Disease; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Follow-Up Studies; Humans; Maxillary Sinusitis; Punctures

2000
[Effectiveness of sparfloxacin (sparflo) in the treatment of complicated forms of pyelonephritis and prostatitis].
    Klinicheskaia meditsina, 2002, Volume: 80, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Pyelonephritis

2002
Single-dose treatment of female acute uncomplicated cystitis.
    Infection, 1992, Volume: 20 Suppl 3

    Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine

1992
[Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1992, Volume: 66, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Cystitis; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Quinolones

1992